Concepedia

Alexander Schammel

AS

Statistics

Publications

4

Citations

154

H-Index

4

Active since

2020

Affiliations

AbbVie (United States)(Current)

National Centre of Scientific Research "Demokritos"

Rice University

Alexander Schammel is an author at AbbVie (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2020–2022

4

Publications

4

Total Synthesis and Biological Evaluation of Tiancimycins A and B, Yangpumicin A, and Related Anthraquinone-Fused Enediyne Antitumor Antibiotics

K. C. Nicolaou, Dipendu Das, Yong Lu et al. · Journal of the American Chemical Society · 2020 · 49 citations

ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors

Wolf R. Wiedemeyer, Julia Gavrilyuk, Alexander Schammel et al. · Molecular Cancer Therapeutics · 2022 · 49 citations · Full text

, , +19

Uncialamycin-based antibody–drug conjugates: Unique enediyne ADCs exhibiting bystander killing effect

K. C. Nicolaou, Stephan Rigol, Emmanuel N. Pitsinos et al. · Proceedings of the National Academy of Sciences · 2021 · 41 citations · Full text

Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody–Drug Conjugates

K. C. Nicolaou, Ruofan Li, Qi‐Feng Chen et al. · Journal of the American Chemical Society · 2020 · 15 citations

, , +16

1–4 of 4